Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00671294 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00671294 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 100 participants.
The verdict
NCT00671294, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This purpose of this study is to assess the efficacy and safety of Ramelteon, once daily (QD), in elderly subjects with chronic insomnia.
Interventions
- DRUG Ramelteon and Placebo (9 possible combinations total)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-10 |
| Est. Completion | 2003-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00671294
The ClinicalTrials.gov registry entry for NCT00671294 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ramelteon and Placebo (9 possible combinations total) is the first listed.
NCT00671294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00671294 about?
NCT00671294 is a clinical study titled "Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.". This purpose of this study is to assess the efficacy and safety of Ramelteon, once daily (QD), in elderly subjects with chronic insomnia.
What is the current status of trial NCT00671294?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2002-10. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00671294?
The interventions under investigation include: Ramelteon and Placebo (9 possible combinations total) (DRUG).
Who is sponsoring clinical trial NCT00671294?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.